Global Anti-CD47 Antibody Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Anti-CD47 Antibody market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
An Anti-CD47 Antibody is a type of antibody that targets the CD47 protein, which is overexpressed in various types of cancer cells. CD47 acts as a "don't eat me" signal, preventing the immune system's macrophages from engulfing and destroying cancer cells. The Anti-CD47 Antibody works by blocking the CD47 protein, thereby allowing the immune system to recognize and eliminate cancer cells effectively. This antibody has shown promise as a potential therapeutic agent in cancer immunotherapy, as it enhances the body's natural immune response against cancer while minimizing toxic side effects.
The industry trend of Anti-CD47 Antibody is highly promising and gaining significant attention in the field of cancer research and drug development. Several pharmaceutical companies and research institutions are actively pursuing the development of Anti-CD47 Antibody-based therapies. There is a growing interest in combining this antibody with other immuno-oncology agents, such as checkpoint inhibitors, to enhance its therapeutic efficacy. Clinical trials evaluating the safety and efficacy of Anti-CD47 Antibody treatments in various cancer types are ongoing and showing encouraging results. The advancement of precision medicine and personalized cancer therapies further supports the potential of Anti-CD47 Antibody as a valuable addition to the oncology treatment armamentarium.
The Global Info Research report includes an overview of the development of the Anti-CD47 Antibody industry chain, the market status of Biotechnology (Monoclonal Antibody, Polyclonal Antibody), Medical (Monoclonal Antibody, Polyclonal Antibody), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anti-CD47 Antibody.
Regionally, the report analyzes the Anti-CD47 Antibody markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anti-CD47 Antibody market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Anti-CD47 Antibody market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anti-CD47 Antibody industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal Antibody, Polyclonal Antibody).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anti-CD47 Antibody market.
Regional Analysis: The report involves examining the Anti-CD47 Antibody market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anti-CD47 Antibody market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Anti-CD47 Antibody:
Company Analysis: Report covers individual Anti-CD47 Antibody players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anti-CD47 Antibody This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biotechnology, Medical).
Technology Analysis: Report covers specific technologies relevant to Anti-CD47 Antibody. It assesses the current state, advancements, and potential future developments in Anti-CD47 Antibody areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anti-CD47 Antibody market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Anti-CD47 Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Anti-CD47 Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-CD47 Antibody, with revenue, gross margin and global market share of Anti-CD47 Antibody from 2019 to 2024.
Chapter 3, the Anti-CD47 Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Anti-CD47 Antibody market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-CD47 Antibody.
Chapter 13, to describe Anti-CD47 Antibody research findings and conclusion.
An Anti-CD47 Antibody is a type of antibody that targets the CD47 protein, which is overexpressed in various types of cancer cells. CD47 acts as a "don't eat me" signal, preventing the immune system's macrophages from engulfing and destroying cancer cells. The Anti-CD47 Antibody works by blocking the CD47 protein, thereby allowing the immune system to recognize and eliminate cancer cells effectively. This antibody has shown promise as a potential therapeutic agent in cancer immunotherapy, as it enhances the body's natural immune response against cancer while minimizing toxic side effects.
The industry trend of Anti-CD47 Antibody is highly promising and gaining significant attention in the field of cancer research and drug development. Several pharmaceutical companies and research institutions are actively pursuing the development of Anti-CD47 Antibody-based therapies. There is a growing interest in combining this antibody with other immuno-oncology agents, such as checkpoint inhibitors, to enhance its therapeutic efficacy. Clinical trials evaluating the safety and efficacy of Anti-CD47 Antibody treatments in various cancer types are ongoing and showing encouraging results. The advancement of precision medicine and personalized cancer therapies further supports the potential of Anti-CD47 Antibody as a valuable addition to the oncology treatment armamentarium.
The Global Info Research report includes an overview of the development of the Anti-CD47 Antibody industry chain, the market status of Biotechnology (Monoclonal Antibody, Polyclonal Antibody), Medical (Monoclonal Antibody, Polyclonal Antibody), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anti-CD47 Antibody.
Regionally, the report analyzes the Anti-CD47 Antibody markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anti-CD47 Antibody market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Anti-CD47 Antibody market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anti-CD47 Antibody industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal Antibody, Polyclonal Antibody).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anti-CD47 Antibody market.
Regional Analysis: The report involves examining the Anti-CD47 Antibody market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anti-CD47 Antibody market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Anti-CD47 Antibody:
Company Analysis: Report covers individual Anti-CD47 Antibody players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anti-CD47 Antibody This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biotechnology, Medical).
Technology Analysis: Report covers specific technologies relevant to Anti-CD47 Antibody. It assesses the current state, advancements, and potential future developments in Anti-CD47 Antibody areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anti-CD47 Antibody market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Anti-CD47 Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Monoclonal Antibody
- Polyclonal Antibody
- Biotechnology
- Medical
- University
- Others
- BosterBio
- Leinco Technologies
- Bioss
- Novus Biologicals
- Thermo Fisher Scientific
- Biorbyt
- Abbexa
- Bio X Cell
- GeneTex
- R&D Systems
- LSBio
- MyBioSource
- ProSci
- antibodies-online
- ABclonal Technology
- Abnova Corporation
- G Biosciences
- BioLegend
- Bio-Rad
- Huabio
- BPS Bioscience
- OriGene Technologies
- St John's Laboratory
- Absolute Antibody
- NSJ Bioreagents
- Cell Signaling Technology
- RayBiotech
- Beijing Solarbio Science & Technology
- Bethyl Laboratories
- Abeomics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Anti-CD47 Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-CD47 Antibody, with revenue, gross margin and global market share of Anti-CD47 Antibody from 2019 to 2024.
Chapter 3, the Anti-CD47 Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Anti-CD47 Antibody market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-CD47 Antibody.
Chapter 13, to describe Anti-CD47 Antibody research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Anti-CD47 Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anti-CD47 Antibody by Type
1.3.1 Overview: Global Anti-CD47 Antibody Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Anti-CD47 Antibody Consumption Value Market Share by Type in 2023
1.3.3 Monoclonal Antibody
1.3.4 Polyclonal Antibody
1.4 Global Anti-CD47 Antibody Market by Application
1.4.1 Overview: Global Anti-CD47 Antibody Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Biotechnology
1.4.3 Medical
1.4.4 University
1.4.5 Others
1.5 Global Anti-CD47 Antibody Market Size & Forecast
1.6 Global Anti-CD47 Antibody Market Size and Forecast by Region
1.6.1 Global Anti-CD47 Antibody Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Anti-CD47 Antibody Market Size by Region, (2019-2030)
1.6.3 North America Anti-CD47 Antibody Market Size and Prospect (2019-2030)
1.6.4 Europe Anti-CD47 Antibody Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Anti-CD47 Antibody Market Size and Prospect (2019-2030)
1.6.6 South America Anti-CD47 Antibody Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Anti-CD47 Antibody Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 BosterBio
2.1.1 BosterBio Details
2.1.2 BosterBio Major Business
2.1.3 BosterBio Anti-CD47 Antibody Product and Solutions
2.1.4 BosterBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BosterBio Recent Developments and Future Plans
2.2 Leinco Technologies
2.2.1 Leinco Technologies Details
2.2.2 Leinco Technologies Major Business
2.2.3 Leinco Technologies Anti-CD47 Antibody Product and Solutions
2.2.4 Leinco Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Leinco Technologies Recent Developments and Future Plans
2.3 Bioss
2.3.1 Bioss Details
2.3.2 Bioss Major Business
2.3.3 Bioss Anti-CD47 Antibody Product and Solutions
2.3.4 Bioss Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bioss Recent Developments and Future Plans
2.4 Novus Biologicals
2.4.1 Novus Biologicals Details
2.4.2 Novus Biologicals Major Business
2.4.3 Novus Biologicals Anti-CD47 Antibody Product and Solutions
2.4.4 Novus Biologicals Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novus Biologicals Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Anti-CD47 Antibody Product and Solutions
2.5.4 Thermo Fisher Scientific Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Biorbyt
2.6.1 Biorbyt Details
2.6.2 Biorbyt Major Business
2.6.3 Biorbyt Anti-CD47 Antibody Product and Solutions
2.6.4 Biorbyt Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Biorbyt Recent Developments and Future Plans
2.7 Abbexa
2.7.1 Abbexa Details
2.7.2 Abbexa Major Business
2.7.3 Abbexa Anti-CD47 Antibody Product and Solutions
2.7.4 Abbexa Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbexa Recent Developments and Future Plans
2.8 Bio X Cell
2.8.1 Bio X Cell Details
2.8.2 Bio X Cell Major Business
2.8.3 Bio X Cell Anti-CD47 Antibody Product and Solutions
2.8.4 Bio X Cell Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bio X Cell Recent Developments and Future Plans
2.9 GeneTex
2.9.1 GeneTex Details
2.9.2 GeneTex Major Business
2.9.3 GeneTex Anti-CD47 Antibody Product and Solutions
2.9.4 GeneTex Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 GeneTex Recent Developments and Future Plans
2.10 R&D Systems
2.10.1 R&D Systems Details
2.10.2 R&D Systems Major Business
2.10.3 R&D Systems Anti-CD47 Antibody Product and Solutions
2.10.4 R&D Systems Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 R&D Systems Recent Developments and Future Plans
2.11 LSBio
2.11.1 LSBio Details
2.11.2 LSBio Major Business
2.11.3 LSBio Anti-CD47 Antibody Product and Solutions
2.11.4 LSBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 LSBio Recent Developments and Future Plans
2.12 MyBioSource
2.12.1 MyBioSource Details
2.12.2 MyBioSource Major Business
2.12.3 MyBioSource Anti-CD47 Antibody Product and Solutions
2.12.4 MyBioSource Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 MyBioSource Recent Developments and Future Plans
2.13 ProSci
2.13.1 ProSci Details
2.13.2 ProSci Major Business
2.13.3 ProSci Anti-CD47 Antibody Product and Solutions
2.13.4 ProSci Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 ProSci Recent Developments and Future Plans
2.14 antibodies-online
2.14.1 antibodies-online Details
2.14.2 antibodies-online Major Business
2.14.3 antibodies-online Anti-CD47 Antibody Product and Solutions
2.14.4 antibodies-online Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 antibodies-online Recent Developments and Future Plans
2.15 ABclonal Technology
2.15.1 ABclonal Technology Details
2.15.2 ABclonal Technology Major Business
2.15.3 ABclonal Technology Anti-CD47 Antibody Product and Solutions
2.15.4 ABclonal Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 ABclonal Technology Recent Developments and Future Plans
2.16 Abnova Corporation
2.16.1 Abnova Corporation Details
2.16.2 Abnova Corporation Major Business
2.16.3 Abnova Corporation Anti-CD47 Antibody Product and Solutions
2.16.4 Abnova Corporation Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Abnova Corporation Recent Developments and Future Plans
2.17 G Biosciences
2.17.1 G Biosciences Details
2.17.2 G Biosciences Major Business
2.17.3 G Biosciences Anti-CD47 Antibody Product and Solutions
2.17.4 G Biosciences Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 G Biosciences Recent Developments and Future Plans
2.18 BioLegend
2.18.1 BioLegend Details
2.18.2 BioLegend Major Business
2.18.3 BioLegend Anti-CD47 Antibody Product and Solutions
2.18.4 BioLegend Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 BioLegend Recent Developments and Future Plans
2.19 Bio-Rad
2.19.1 Bio-Rad Details
2.19.2 Bio-Rad Major Business
2.19.3 Bio-Rad Anti-CD47 Antibody Product and Solutions
2.19.4 Bio-Rad Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Bio-Rad Recent Developments and Future Plans
2.20 Huabio
2.20.1 Huabio Details
2.20.2 Huabio Major Business
2.20.3 Huabio Anti-CD47 Antibody Product and Solutions
2.20.4 Huabio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Huabio Recent Developments and Future Plans
2.21 BPS Bioscience
2.21.1 BPS Bioscience Details
2.21.2 BPS Bioscience Major Business
2.21.3 BPS Bioscience Anti-CD47 Antibody Product and Solutions
2.21.4 BPS Bioscience Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 BPS Bioscience Recent Developments and Future Plans
2.22 OriGene Technologies
2.22.1 OriGene Technologies Details
2.22.2 OriGene Technologies Major Business
2.22.3 OriGene Technologies Anti-CD47 Antibody Product and Solutions
2.22.4 OriGene Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 OriGene Technologies Recent Developments and Future Plans
2.23 St John's Laboratory
2.23.1 St John's Laboratory Details
2.23.2 St John's Laboratory Major Business
2.23.3 St John's Laboratory Anti-CD47 Antibody Product and Solutions
2.23.4 St John's Laboratory Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 St John's Laboratory Recent Developments and Future Plans
2.24 Absolute Antibody
2.24.1 Absolute Antibody Details
2.24.2 Absolute Antibody Major Business
2.24.3 Absolute Antibody Anti-CD47 Antibody Product and Solutions
2.24.4 Absolute Antibody Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 Absolute Antibody Recent Developments and Future Plans
2.25 NSJ Bioreagents
2.25.1 NSJ Bioreagents Details
2.25.2 NSJ Bioreagents Major Business
2.25.3 NSJ Bioreagents Anti-CD47 Antibody Product and Solutions
2.25.4 NSJ Bioreagents Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.25.5 NSJ Bioreagents Recent Developments and Future Plans
2.26 Cell Signaling Technology
2.26.1 Cell Signaling Technology Details
2.26.2 Cell Signaling Technology Major Business
2.26.3 Cell Signaling Technology Anti-CD47 Antibody Product and Solutions
2.26.4 Cell Signaling Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.26.5 Cell Signaling Technology Recent Developments and Future Plans
2.27 RayBiotech
2.27.1 RayBiotech Details
2.27.2 RayBiotech Major Business
2.27.3 RayBiotech Anti-CD47 Antibody Product and Solutions
2.27.4 RayBiotech Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.27.5 RayBiotech Recent Developments and Future Plans
2.28 Beijing Solarbio Science & Technology
2.28.1 Beijing Solarbio Science & Technology Details
2.28.2 Beijing Solarbio Science & Technology Major Business
2.28.3 Beijing Solarbio Science & Technology Anti-CD47 Antibody Product and Solutions
2.28.4 Beijing Solarbio Science & Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.28.5 Beijing Solarbio Science & Technology Recent Developments and Future Plans
2.29 Bethyl Laboratories
2.29.1 Bethyl Laboratories Details
2.29.2 Bethyl Laboratories Major Business
2.29.3 Bethyl Laboratories Anti-CD47 Antibody Product and Solutions
2.29.4 Bethyl Laboratories Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.29.5 Bethyl Laboratories Recent Developments and Future Plans
2.30 Abeomics
2.30.1 Abeomics Details
2.30.2 Abeomics Major Business
2.30.3 Abeomics Anti-CD47 Antibody Product and Solutions
2.30.4 Abeomics Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.30.5 Abeomics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Anti-CD47 Antibody Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Anti-CD47 Antibody by Company Revenue
3.2.2 Top 3 Anti-CD47 Antibody Players Market Share in 2023
3.2.3 Top 6 Anti-CD47 Antibody Players Market Share in 2023
3.3 Anti-CD47 Antibody Market: Overall Company Footprint Analysis
3.3.1 Anti-CD47 Antibody Market: Region Footprint
3.3.2 Anti-CD47 Antibody Market: Company Product Type Footprint
3.3.3 Anti-CD47 Antibody Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Anti-CD47 Antibody Consumption Value and Market Share by Type (2019-2024)
4.2 Global Anti-CD47 Antibody Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2024)
5.2 Global Anti-CD47 Antibody Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Anti-CD47 Antibody Consumption Value by Type (2019-2030)
6.2 North America Anti-CD47 Antibody Consumption Value by Application (2019-2030)
6.3 North America Anti-CD47 Antibody Market Size by Country
6.3.1 North America Anti-CD47 Antibody Consumption Value by Country (2019-2030)
6.3.2 United States Anti-CD47 Antibody Market Size and Forecast (2019-2030)
6.3.3 Canada Anti-CD47 Antibody Market Size and Forecast (2019-2030)
6.3.4 Mexico Anti-CD47 Antibody Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Anti-CD47 Antibody Consumption Value by Type (2019-2030)
7.2 Europe Anti-CD47 Antibody Consumption Value by Application (2019-2030)
7.3 Europe Anti-CD47 Antibody Market Size by Country
7.3.1 Europe Anti-CD47 Antibody Consumption Value by Country (2019-2030)
7.3.2 Germany Anti-CD47 Antibody Market Size and Forecast (2019-2030)
7.3.3 France Anti-CD47 Antibody Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Anti-CD47 Antibody Market Size and Forecast (2019-2030)
7.3.5 Russia Anti-CD47 Antibody Market Size and Forecast (2019-2030)
7.3.6 Italy Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Anti-CD47 Antibody Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Anti-CD47 Antibody Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Anti-CD47 Antibody Market Size by Region
8.3.1 Asia-Pacific Anti-CD47 Antibody Consumption Value by Region (2019-2030)
8.3.2 China Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8.3.3 Japan Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8.3.4 South Korea Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8.3.5 India Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8.3.7 Australia Anti-CD47 Antibody Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Anti-CD47 Antibody Consumption Value by Type (2019-2030)
9.2 South America Anti-CD47 Antibody Consumption Value by Application (2019-2030)
9.3 South America Anti-CD47 Antibody Market Size by Country
9.3.1 South America Anti-CD47 Antibody Consumption Value by Country (2019-2030)
9.3.2 Brazil Anti-CD47 Antibody Market Size and Forecast (2019-2030)
9.3.3 Argentina Anti-CD47 Antibody Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Anti-CD47 Antibody Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Anti-CD47 Antibody Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Anti-CD47 Antibody Market Size by Country
10.3.1 Middle East & Africa Anti-CD47 Antibody Consumption Value by Country (2019-2030)
10.3.2 Turkey Anti-CD47 Antibody Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Anti-CD47 Antibody Market Size and Forecast (2019-2030)
10.3.4 UAE Anti-CD47 Antibody Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Anti-CD47 Antibody Market Drivers
11.2 Anti-CD47 Antibody Market Restraints
11.3 Anti-CD47 Antibody Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Anti-CD47 Antibody Industry Chain
12.2 Anti-CD47 Antibody Upstream Analysis
12.3 Anti-CD47 Antibody Midstream Analysis
12.4 Anti-CD47 Antibody Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Anti-CD47 Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anti-CD47 Antibody by Type
1.3.1 Overview: Global Anti-CD47 Antibody Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Anti-CD47 Antibody Consumption Value Market Share by Type in 2023
1.3.3 Monoclonal Antibody
1.3.4 Polyclonal Antibody
1.4 Global Anti-CD47 Antibody Market by Application
1.4.1 Overview: Global Anti-CD47 Antibody Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Biotechnology
1.4.3 Medical
1.4.4 University
1.4.5 Others
1.5 Global Anti-CD47 Antibody Market Size & Forecast
1.6 Global Anti-CD47 Antibody Market Size and Forecast by Region
1.6.1 Global Anti-CD47 Antibody Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Anti-CD47 Antibody Market Size by Region, (2019-2030)
1.6.3 North America Anti-CD47 Antibody Market Size and Prospect (2019-2030)
1.6.4 Europe Anti-CD47 Antibody Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Anti-CD47 Antibody Market Size and Prospect (2019-2030)
1.6.6 South America Anti-CD47 Antibody Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Anti-CD47 Antibody Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 BosterBio
2.1.1 BosterBio Details
2.1.2 BosterBio Major Business
2.1.3 BosterBio Anti-CD47 Antibody Product and Solutions
2.1.4 BosterBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BosterBio Recent Developments and Future Plans
2.2 Leinco Technologies
2.2.1 Leinco Technologies Details
2.2.2 Leinco Technologies Major Business
2.2.3 Leinco Technologies Anti-CD47 Antibody Product and Solutions
2.2.4 Leinco Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Leinco Technologies Recent Developments and Future Plans
2.3 Bioss
2.3.1 Bioss Details
2.3.2 Bioss Major Business
2.3.3 Bioss Anti-CD47 Antibody Product and Solutions
2.3.4 Bioss Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bioss Recent Developments and Future Plans
2.4 Novus Biologicals
2.4.1 Novus Biologicals Details
2.4.2 Novus Biologicals Major Business
2.4.3 Novus Biologicals Anti-CD47 Antibody Product and Solutions
2.4.4 Novus Biologicals Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novus Biologicals Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Anti-CD47 Antibody Product and Solutions
2.5.4 Thermo Fisher Scientific Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Biorbyt
2.6.1 Biorbyt Details
2.6.2 Biorbyt Major Business
2.6.3 Biorbyt Anti-CD47 Antibody Product and Solutions
2.6.4 Biorbyt Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Biorbyt Recent Developments and Future Plans
2.7 Abbexa
2.7.1 Abbexa Details
2.7.2 Abbexa Major Business
2.7.3 Abbexa Anti-CD47 Antibody Product and Solutions
2.7.4 Abbexa Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbexa Recent Developments and Future Plans
2.8 Bio X Cell
2.8.1 Bio X Cell Details
2.8.2 Bio X Cell Major Business
2.8.3 Bio X Cell Anti-CD47 Antibody Product and Solutions
2.8.4 Bio X Cell Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bio X Cell Recent Developments and Future Plans
2.9 GeneTex
2.9.1 GeneTex Details
2.9.2 GeneTex Major Business
2.9.3 GeneTex Anti-CD47 Antibody Product and Solutions
2.9.4 GeneTex Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 GeneTex Recent Developments and Future Plans
2.10 R&D Systems
2.10.1 R&D Systems Details
2.10.2 R&D Systems Major Business
2.10.3 R&D Systems Anti-CD47 Antibody Product and Solutions
2.10.4 R&D Systems Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 R&D Systems Recent Developments and Future Plans
2.11 LSBio
2.11.1 LSBio Details
2.11.2 LSBio Major Business
2.11.3 LSBio Anti-CD47 Antibody Product and Solutions
2.11.4 LSBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 LSBio Recent Developments and Future Plans
2.12 MyBioSource
2.12.1 MyBioSource Details
2.12.2 MyBioSource Major Business
2.12.3 MyBioSource Anti-CD47 Antibody Product and Solutions
2.12.4 MyBioSource Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 MyBioSource Recent Developments and Future Plans
2.13 ProSci
2.13.1 ProSci Details
2.13.2 ProSci Major Business
2.13.3 ProSci Anti-CD47 Antibody Product and Solutions
2.13.4 ProSci Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 ProSci Recent Developments and Future Plans
2.14 antibodies-online
2.14.1 antibodies-online Details
2.14.2 antibodies-online Major Business
2.14.3 antibodies-online Anti-CD47 Antibody Product and Solutions
2.14.4 antibodies-online Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 antibodies-online Recent Developments and Future Plans
2.15 ABclonal Technology
2.15.1 ABclonal Technology Details
2.15.2 ABclonal Technology Major Business
2.15.3 ABclonal Technology Anti-CD47 Antibody Product and Solutions
2.15.4 ABclonal Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 ABclonal Technology Recent Developments and Future Plans
2.16 Abnova Corporation
2.16.1 Abnova Corporation Details
2.16.2 Abnova Corporation Major Business
2.16.3 Abnova Corporation Anti-CD47 Antibody Product and Solutions
2.16.4 Abnova Corporation Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Abnova Corporation Recent Developments and Future Plans
2.17 G Biosciences
2.17.1 G Biosciences Details
2.17.2 G Biosciences Major Business
2.17.3 G Biosciences Anti-CD47 Antibody Product and Solutions
2.17.4 G Biosciences Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 G Biosciences Recent Developments and Future Plans
2.18 BioLegend
2.18.1 BioLegend Details
2.18.2 BioLegend Major Business
2.18.3 BioLegend Anti-CD47 Antibody Product and Solutions
2.18.4 BioLegend Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 BioLegend Recent Developments and Future Plans
2.19 Bio-Rad
2.19.1 Bio-Rad Details
2.19.2 Bio-Rad Major Business
2.19.3 Bio-Rad Anti-CD47 Antibody Product and Solutions
2.19.4 Bio-Rad Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Bio-Rad Recent Developments and Future Plans
2.20 Huabio
2.20.1 Huabio Details
2.20.2 Huabio Major Business
2.20.3 Huabio Anti-CD47 Antibody Product and Solutions
2.20.4 Huabio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Huabio Recent Developments and Future Plans
2.21 BPS Bioscience
2.21.1 BPS Bioscience Details
2.21.2 BPS Bioscience Major Business
2.21.3 BPS Bioscience Anti-CD47 Antibody Product and Solutions
2.21.4 BPS Bioscience Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 BPS Bioscience Recent Developments and Future Plans
2.22 OriGene Technologies
2.22.1 OriGene Technologies Details
2.22.2 OriGene Technologies Major Business
2.22.3 OriGene Technologies Anti-CD47 Antibody Product and Solutions
2.22.4 OriGene Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 OriGene Technologies Recent Developments and Future Plans
2.23 St John's Laboratory
2.23.1 St John's Laboratory Details
2.23.2 St John's Laboratory Major Business
2.23.3 St John's Laboratory Anti-CD47 Antibody Product and Solutions
2.23.4 St John's Laboratory Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 St John's Laboratory Recent Developments and Future Plans
2.24 Absolute Antibody
2.24.1 Absolute Antibody Details
2.24.2 Absolute Antibody Major Business
2.24.3 Absolute Antibody Anti-CD47 Antibody Product and Solutions
2.24.4 Absolute Antibody Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 Absolute Antibody Recent Developments and Future Plans
2.25 NSJ Bioreagents
2.25.1 NSJ Bioreagents Details
2.25.2 NSJ Bioreagents Major Business
2.25.3 NSJ Bioreagents Anti-CD47 Antibody Product and Solutions
2.25.4 NSJ Bioreagents Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.25.5 NSJ Bioreagents Recent Developments and Future Plans
2.26 Cell Signaling Technology
2.26.1 Cell Signaling Technology Details
2.26.2 Cell Signaling Technology Major Business
2.26.3 Cell Signaling Technology Anti-CD47 Antibody Product and Solutions
2.26.4 Cell Signaling Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.26.5 Cell Signaling Technology Recent Developments and Future Plans
2.27 RayBiotech
2.27.1 RayBiotech Details
2.27.2 RayBiotech Major Business
2.27.3 RayBiotech Anti-CD47 Antibody Product and Solutions
2.27.4 RayBiotech Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.27.5 RayBiotech Recent Developments and Future Plans
2.28 Beijing Solarbio Science & Technology
2.28.1 Beijing Solarbio Science & Technology Details
2.28.2 Beijing Solarbio Science & Technology Major Business
2.28.3 Beijing Solarbio Science & Technology Anti-CD47 Antibody Product and Solutions
2.28.4 Beijing Solarbio Science & Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.28.5 Beijing Solarbio Science & Technology Recent Developments and Future Plans
2.29 Bethyl Laboratories
2.29.1 Bethyl Laboratories Details
2.29.2 Bethyl Laboratories Major Business
2.29.3 Bethyl Laboratories Anti-CD47 Antibody Product and Solutions
2.29.4 Bethyl Laboratories Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.29.5 Bethyl Laboratories Recent Developments and Future Plans
2.30 Abeomics
2.30.1 Abeomics Details
2.30.2 Abeomics Major Business
2.30.3 Abeomics Anti-CD47 Antibody Product and Solutions
2.30.4 Abeomics Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.30.5 Abeomics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Anti-CD47 Antibody Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Anti-CD47 Antibody by Company Revenue
3.2.2 Top 3 Anti-CD47 Antibody Players Market Share in 2023
3.2.3 Top 6 Anti-CD47 Antibody Players Market Share in 2023
3.3 Anti-CD47 Antibody Market: Overall Company Footprint Analysis
3.3.1 Anti-CD47 Antibody Market: Region Footprint
3.3.2 Anti-CD47 Antibody Market: Company Product Type Footprint
3.3.3 Anti-CD47 Antibody Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Anti-CD47 Antibody Consumption Value and Market Share by Type (2019-2024)
4.2 Global Anti-CD47 Antibody Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2024)
5.2 Global Anti-CD47 Antibody Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Anti-CD47 Antibody Consumption Value by Type (2019-2030)
6.2 North America Anti-CD47 Antibody Consumption Value by Application (2019-2030)
6.3 North America Anti-CD47 Antibody Market Size by Country
6.3.1 North America Anti-CD47 Antibody Consumption Value by Country (2019-2030)
6.3.2 United States Anti-CD47 Antibody Market Size and Forecast (2019-2030)
6.3.3 Canada Anti-CD47 Antibody Market Size and Forecast (2019-2030)
6.3.4 Mexico Anti-CD47 Antibody Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Anti-CD47 Antibody Consumption Value by Type (2019-2030)
7.2 Europe Anti-CD47 Antibody Consumption Value by Application (2019-2030)
7.3 Europe Anti-CD47 Antibody Market Size by Country
7.3.1 Europe Anti-CD47 Antibody Consumption Value by Country (2019-2030)
7.3.2 Germany Anti-CD47 Antibody Market Size and Forecast (2019-2030)
7.3.3 France Anti-CD47 Antibody Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Anti-CD47 Antibody Market Size and Forecast (2019-2030)
7.3.5 Russia Anti-CD47 Antibody Market Size and Forecast (2019-2030)
7.3.6 Italy Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Anti-CD47 Antibody Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Anti-CD47 Antibody Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Anti-CD47 Antibody Market Size by Region
8.3.1 Asia-Pacific Anti-CD47 Antibody Consumption Value by Region (2019-2030)
8.3.2 China Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8.3.3 Japan Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8.3.4 South Korea Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8.3.5 India Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Anti-CD47 Antibody Market Size and Forecast (2019-2030)
8.3.7 Australia Anti-CD47 Antibody Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Anti-CD47 Antibody Consumption Value by Type (2019-2030)
9.2 South America Anti-CD47 Antibody Consumption Value by Application (2019-2030)
9.3 South America Anti-CD47 Antibody Market Size by Country
9.3.1 South America Anti-CD47 Antibody Consumption Value by Country (2019-2030)
9.3.2 Brazil Anti-CD47 Antibody Market Size and Forecast (2019-2030)
9.3.3 Argentina Anti-CD47 Antibody Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Anti-CD47 Antibody Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Anti-CD47 Antibody Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Anti-CD47 Antibody Market Size by Country
10.3.1 Middle East & Africa Anti-CD47 Antibody Consumption Value by Country (2019-2030)
10.3.2 Turkey Anti-CD47 Antibody Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Anti-CD47 Antibody Market Size and Forecast (2019-2030)
10.3.4 UAE Anti-CD47 Antibody Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Anti-CD47 Antibody Market Drivers
11.2 Anti-CD47 Antibody Market Restraints
11.3 Anti-CD47 Antibody Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Anti-CD47 Antibody Industry Chain
12.2 Anti-CD47 Antibody Upstream Analysis
12.3 Anti-CD47 Antibody Midstream Analysis
12.4 Anti-CD47 Antibody Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
.
Table 1. Global Anti-CD47 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Anti-CD47 Antibody Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Anti-CD47 Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Anti-CD47 Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 5. BosterBio Company Information, Head Office, and Major Competitors
Table 6. BosterBio Major Business
Table 7. BosterBio Anti-CD47 Antibody Product and Solutions
Table 8. BosterBio Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. BosterBio Recent Developments and Future Plans
Table 10. Leinco Technologies Company Information, Head Office, and Major Competitors
Table 11. Leinco Technologies Major Business
Table 12. Leinco Technologies Anti-CD47 Antibody Product and Solutions
Table 13. Leinco Technologies Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Leinco Technologies Recent Developments and Future Plans
Table 15. Bioss Company Information, Head Office, and Major Competitors
Table 16. Bioss Major Business
Table 17. Bioss Anti-CD47 Antibody Product and Solutions
Table 18. Bioss Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bioss Recent Developments and Future Plans
Table 20. Novus Biologicals Company Information, Head Office, and Major Competitors
Table 21. Novus Biologicals Major Business
Table 22. Novus Biologicals Anti-CD47 Antibody Product and Solutions
Table 23. Novus Biologicals Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novus Biologicals Recent Developments and Future Plans
Table 25. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 26. Thermo Fisher Scientific Major Business
Table 27. Thermo Fisher Scientific Anti-CD47 Antibody Product and Solutions
Table 28. Thermo Fisher Scientific Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Thermo Fisher Scientific Recent Developments and Future Plans
Table 30. Biorbyt Company Information, Head Office, and Major Competitors
Table 31. Biorbyt Major Business
Table 32. Biorbyt Anti-CD47 Antibody Product and Solutions
Table 33. Biorbyt Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Biorbyt Recent Developments and Future Plans
Table 35. Abbexa Company Information, Head Office, and Major Competitors
Table 36. Abbexa Major Business
Table 37. Abbexa Anti-CD47 Antibody Product and Solutions
Table 38. Abbexa Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Abbexa Recent Developments and Future Plans
Table 40. Bio X Cell Company Information, Head Office, and Major Competitors
Table 41. Bio X Cell Major Business
Table 42. Bio X Cell Anti-CD47 Antibody Product and Solutions
Table 43. Bio X Cell Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bio X Cell Recent Developments and Future Plans
Table 45. GeneTex Company Information, Head Office, and Major Competitors
Table 46. GeneTex Major Business
Table 47. GeneTex Anti-CD47 Antibody Product and Solutions
Table 48. GeneTex Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. GeneTex Recent Developments and Future Plans
Table 50. R&D Systems Company Information, Head Office, and Major Competitors
Table 51. R&D Systems Major Business
Table 52. R&D Systems Anti-CD47 Antibody Product and Solutions
Table 53. R&D Systems Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. R&D Systems Recent Developments and Future Plans
Table 55. LSBio Company Information, Head Office, and Major Competitors
Table 56. LSBio Major Business
Table 57. LSBio Anti-CD47 Antibody Product and Solutions
Table 58. LSBio Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. LSBio Recent Developments and Future Plans
Table 60. MyBioSource Company Information, Head Office, and Major Competitors
Table 61. MyBioSource Major Business
Table 62. MyBioSource Anti-CD47 Antibody Product and Solutions
Table 63. MyBioSource Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. MyBioSource Recent Developments and Future Plans
Table 65. ProSci Company Information, Head Office, and Major Competitors
Table 66. ProSci Major Business
Table 67. ProSci Anti-CD47 Antibody Product and Solutions
Table 68. ProSci Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. ProSci Recent Developments and Future Plans
Table 70. antibodies-online Company Information, Head Office, and Major Competitors
Table 71. antibodies-online Major Business
Table 72. antibodies-online Anti-CD47 Antibody Product and Solutions
Table 73. antibodies-online Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. antibodies-online Recent Developments and Future Plans
Table 75. ABclonal Technology Company Information, Head Office, and Major Competitors
Table 76. ABclonal Technology Major Business
Table 77. ABclonal Technology Anti-CD47 Antibody Product and Solutions
Table 78. ABclonal Technology Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. ABclonal Technology Recent Developments and Future Plans
Table 80. Abnova Corporation Company Information, Head Office, and Major Competitors
Table 81. Abnova Corporation Major Business
Table 82. Abnova Corporation Anti-CD47 Antibody Product and Solutions
Table 83. Abnova Corporation Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Abnova Corporation Recent Developments and Future Plans
Table 85. G Biosciences Company Information, Head Office, and Major Competitors
Table 86. G Biosciences Major Business
Table 87. G Biosciences Anti-CD47 Antibody Product and Solutions
Table 88. G Biosciences Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. G Biosciences Recent Developments and Future Plans
Table 90. BioLegend Company Information, Head Office, and Major Competitors
Table 91. BioLegend Major Business
Table 92. BioLegend Anti-CD47 Antibody Product and Solutions
Table 93. BioLegend Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. BioLegend Recent Developments and Future Plans
Table 95. Bio-Rad Company Information, Head Office, and Major Competitors
Table 96. Bio-Rad Major Business
Table 97. Bio-Rad Anti-CD47 Antibody Product and Solutions
Table 98. Bio-Rad Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Bio-Rad Recent Developments and Future Plans
Table 100. Huabio Company Information, Head Office, and Major Competitors
Table 101. Huabio Major Business
Table 102. Huabio Anti-CD47 Antibody Product and Solutions
Table 103. Huabio Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Huabio Recent Developments and Future Plans
Table 105. BPS Bioscience Company Information, Head Office, and Major Competitors
Table 106. BPS Bioscience Major Business
Table 107. BPS Bioscience Anti-CD47 Antibody Product and Solutions
Table 108. BPS Bioscience Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. BPS Bioscience Recent Developments and Future Plans
Table 110. OriGene Technologies Company Information, Head Office, and Major Competitors
Table 111. OriGene Technologies Major Business
Table 112. OriGene Technologies Anti-CD47 Antibody Product and Solutions
Table 113. OriGene Technologies Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. OriGene Technologies Recent Developments and Future Plans
Table 115. St John's Laboratory Company Information, Head Office, and Major Competitors
Table 116. St John's Laboratory Major Business
Table 117. St John's Laboratory Anti-CD47 Antibody Product and Solutions
Table 118. St John's Laboratory Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. St John's Laboratory Recent Developments and Future Plans
Table 120. Absolute Antibody Company Information, Head Office, and Major Competitors
Table 121. Absolute Antibody Major Business
Table 122. Absolute Antibody Anti-CD47 Antibody Product and Solutions
Table 123. Absolute Antibody Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. Absolute Antibody Recent Developments and Future Plans
Table 125. NSJ Bioreagents Company Information, Head Office, and Major Competitors
Table 126. NSJ Bioreagents Major Business
Table 127. NSJ Bioreagents Anti-CD47 Antibody Product and Solutions
Table 128. NSJ Bioreagents Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 129. NSJ Bioreagents Recent Developments and Future Plans
Table 130. Cell Signaling Technology Company Information, Head Office, and Major Competitors
Table 131. Cell Signaling Technology Major Business
Table 132. Cell Signaling Technology Anti-CD47 Antibody Product and Solutions
Table 133. Cell Signaling Technology Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 134. Cell Signaling Technology Recent Developments and Future Plans
Table 135. RayBiotech Company Information, Head Office, and Major Competitors
Table 136. RayBiotech Major Business
Table 137. RayBiotech Anti-CD47 Antibody Product and Solutions
Table 138. RayBiotech Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 139. RayBiotech Recent Developments and Future Plans
Table 140. Beijing Solarbio Science & Technology Company Information, Head Office, and Major Competitors
Table 141. Beijing Solarbio Science & Technology Major Business
Table 142. Beijing Solarbio Science & Technology Anti-CD47 Antibody Product and Solutions
Table 143. Beijing Solarbio Science & Technology Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 144. Beijing Solarbio Science & Technology Recent Developments and Future Plans
Table 145. Bethyl Laboratories Company Information, Head Office, and Major Competitors
Table 146. Bethyl Laboratories Major Business
Table 147. Bethyl Laboratories Anti-CD47 Antibody Product and Solutions
Table 148. Bethyl Laboratories Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Bethyl Laboratories Recent Developments and Future Plans
Table 150. Abeomics Company Information, Head Office, and Major Competitors
Table 151. Abeomics Major Business
Table 152. Abeomics Anti-CD47 Antibody Product and Solutions
Table 153. Abeomics Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 154. Abeomics Recent Developments and Future Plans
Table 155. Global Anti-CD47 Antibody Revenue (USD Million) by Players (2019-2024)
Table 156. Global Anti-CD47 Antibody Revenue Share by Players (2019-2024)
Table 157. Breakdown of Anti-CD47 Antibody by Company Type (Tier 1, Tier 2, and Tier 3)
Table 158. Market Position of Players in Anti-CD47 Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 159. Head Office of Key Anti-CD47 Antibody Players
Table 160. Anti-CD47 Antibody Market: Company Product Type Footprint
Table 161. Anti-CD47 Antibody Market: Company Product Application Footprint
Table 162. Anti-CD47 Antibody New Market Entrants and Barriers to Market Entry
Table 163. Anti-CD47 Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 164. Global Anti-CD47 Antibody Consumption Value (USD Million) by Type (2019-2024)
Table 165. Global Anti-CD47 Antibody Consumption Value Share by Type (2019-2024)
Table 166. Global Anti-CD47 Antibody Consumption Value Forecast by Type (2025-2030)
Table 167. Global Anti-CD47 Antibody Consumption Value by Application (2019-2024)
Table 168. Global Anti-CD47 Antibody Consumption Value Forecast by Application (2025-2030)
Table 169. North America Anti-CD47 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 170. North America Anti-CD47 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 171. North America Anti-CD47 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 172. North America Anti-CD47 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 173. North America Anti-CD47 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 174. North America Anti-CD47 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 175. Europe Anti-CD47 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 176. Europe Anti-CD47 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 177. Europe Anti-CD47 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 178. Europe Anti-CD47 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 179. Europe Anti-CD47 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 180. Europe Anti-CD47 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 181. Asia-Pacific Anti-CD47 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 182. Asia-Pacific Anti-CD47 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 183. Asia-Pacific Anti-CD47 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 184. Asia-Pacific Anti-CD47 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 185. Asia-Pacific Anti-CD47 Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 186. Asia-Pacific Anti-CD47 Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 187. South America Anti-CD47 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 188. South America Anti-CD47 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 189. South America Anti-CD47 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 190. South America Anti-CD47 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 191. South America Anti-CD47 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 192. South America Anti-CD47 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 193. Middle East & Africa Anti-CD47 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 194. Middle East & Africa Anti-CD47 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 195. Middle East & Africa Anti-CD47 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 196. Middle East & Africa Anti-CD47 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 197. Middle East & Africa Anti-CD47 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 198. Middle East & Africa Anti-CD47 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 199. Anti-CD47 Antibody Raw Material
Table 200. Key Suppliers of Anti-CD47 Antibody Raw Materials
LIST OF FIGURE
. s
Figure 1. Anti-CD47 Antibody Picture
Figure 2. Global Anti-CD47 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Anti-CD47 Antibody Consumption Value Market Share by Type in 2023
Figure 4. Monoclonal Antibody
Figure 5. Polyclonal Antibody
Figure 6. Global Anti-CD47 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Anti-CD47 Antibody Consumption Value Market Share by Application in 2023
Figure 8. Biotechnology Picture
Figure 9. Medical Picture
Figure 10. University Picture
Figure 11. Others Picture
Figure 12. Global Anti-CD47 Antibody Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Anti-CD47 Antibody Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Anti-CD47 Antibody Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Anti-CD47 Antibody Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Anti-CD47 Antibody Consumption Value Market Share by Region in 2023
Figure 17. North America Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Anti-CD47 Antibody Revenue Share by Players in 2023
Figure 23. Anti-CD47 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Anti-CD47 Antibody Market Share in 2023
Figure 25. Global Top 6 Players Anti-CD47 Antibody Market Share in 2023
Figure 26. Global Anti-CD47 Antibody Consumption Value Share by Type (2019-2024)
Figure 27. Global Anti-CD47 Antibody Market Share Forecast by Type (2025-2030)
Figure 28. Global Anti-CD47 Antibody Consumption Value Share by Application (2019-2024)
Figure 29. Global Anti-CD47 Antibody Market Share Forecast by Application (2025-2030)
Figure 30. North America Anti-CD47 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Anti-CD47 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Anti-CD47 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Anti-CD47 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 40. France Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Anti-CD47 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Anti-CD47 Antibody Consumption Value Market Share by Region (2019-2030)
Figure 47. China Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 50. India Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Anti-CD47 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Anti-CD47 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Anti-CD47 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Anti-CD47 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 64. Anti-CD47 Antibody Market Drivers
Figure 65. Anti-CD47 Antibody Market Restraints
Figure 66. Anti-CD47 Antibody Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Anti-CD47 Antibody in 2023
Figure 69. Manufacturing Process Analysis of Anti-CD47 Antibody
Figure 70. Anti-CD47 Antibody Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
.
Table 1. Global Anti-CD47 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Anti-CD47 Antibody Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Anti-CD47 Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Anti-CD47 Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 5. BosterBio Company Information, Head Office, and Major Competitors
Table 6. BosterBio Major Business
Table 7. BosterBio Anti-CD47 Antibody Product and Solutions
Table 8. BosterBio Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. BosterBio Recent Developments and Future Plans
Table 10. Leinco Technologies Company Information, Head Office, and Major Competitors
Table 11. Leinco Technologies Major Business
Table 12. Leinco Technologies Anti-CD47 Antibody Product and Solutions
Table 13. Leinco Technologies Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Leinco Technologies Recent Developments and Future Plans
Table 15. Bioss Company Information, Head Office, and Major Competitors
Table 16. Bioss Major Business
Table 17. Bioss Anti-CD47 Antibody Product and Solutions
Table 18. Bioss Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bioss Recent Developments and Future Plans
Table 20. Novus Biologicals Company Information, Head Office, and Major Competitors
Table 21. Novus Biologicals Major Business
Table 22. Novus Biologicals Anti-CD47 Antibody Product and Solutions
Table 23. Novus Biologicals Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novus Biologicals Recent Developments and Future Plans
Table 25. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 26. Thermo Fisher Scientific Major Business
Table 27. Thermo Fisher Scientific Anti-CD47 Antibody Product and Solutions
Table 28. Thermo Fisher Scientific Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Thermo Fisher Scientific Recent Developments and Future Plans
Table 30. Biorbyt Company Information, Head Office, and Major Competitors
Table 31. Biorbyt Major Business
Table 32. Biorbyt Anti-CD47 Antibody Product and Solutions
Table 33. Biorbyt Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Biorbyt Recent Developments and Future Plans
Table 35. Abbexa Company Information, Head Office, and Major Competitors
Table 36. Abbexa Major Business
Table 37. Abbexa Anti-CD47 Antibody Product and Solutions
Table 38. Abbexa Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Abbexa Recent Developments and Future Plans
Table 40. Bio X Cell Company Information, Head Office, and Major Competitors
Table 41. Bio X Cell Major Business
Table 42. Bio X Cell Anti-CD47 Antibody Product and Solutions
Table 43. Bio X Cell Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bio X Cell Recent Developments and Future Plans
Table 45. GeneTex Company Information, Head Office, and Major Competitors
Table 46. GeneTex Major Business
Table 47. GeneTex Anti-CD47 Antibody Product and Solutions
Table 48. GeneTex Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. GeneTex Recent Developments and Future Plans
Table 50. R&D Systems Company Information, Head Office, and Major Competitors
Table 51. R&D Systems Major Business
Table 52. R&D Systems Anti-CD47 Antibody Product and Solutions
Table 53. R&D Systems Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. R&D Systems Recent Developments and Future Plans
Table 55. LSBio Company Information, Head Office, and Major Competitors
Table 56. LSBio Major Business
Table 57. LSBio Anti-CD47 Antibody Product and Solutions
Table 58. LSBio Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. LSBio Recent Developments and Future Plans
Table 60. MyBioSource Company Information, Head Office, and Major Competitors
Table 61. MyBioSource Major Business
Table 62. MyBioSource Anti-CD47 Antibody Product and Solutions
Table 63. MyBioSource Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. MyBioSource Recent Developments and Future Plans
Table 65. ProSci Company Information, Head Office, and Major Competitors
Table 66. ProSci Major Business
Table 67. ProSci Anti-CD47 Antibody Product and Solutions
Table 68. ProSci Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. ProSci Recent Developments and Future Plans
Table 70. antibodies-online Company Information, Head Office, and Major Competitors
Table 71. antibodies-online Major Business
Table 72. antibodies-online Anti-CD47 Antibody Product and Solutions
Table 73. antibodies-online Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. antibodies-online Recent Developments and Future Plans
Table 75. ABclonal Technology Company Information, Head Office, and Major Competitors
Table 76. ABclonal Technology Major Business
Table 77. ABclonal Technology Anti-CD47 Antibody Product and Solutions
Table 78. ABclonal Technology Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. ABclonal Technology Recent Developments and Future Plans
Table 80. Abnova Corporation Company Information, Head Office, and Major Competitors
Table 81. Abnova Corporation Major Business
Table 82. Abnova Corporation Anti-CD47 Antibody Product and Solutions
Table 83. Abnova Corporation Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Abnova Corporation Recent Developments and Future Plans
Table 85. G Biosciences Company Information, Head Office, and Major Competitors
Table 86. G Biosciences Major Business
Table 87. G Biosciences Anti-CD47 Antibody Product and Solutions
Table 88. G Biosciences Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. G Biosciences Recent Developments and Future Plans
Table 90. BioLegend Company Information, Head Office, and Major Competitors
Table 91. BioLegend Major Business
Table 92. BioLegend Anti-CD47 Antibody Product and Solutions
Table 93. BioLegend Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. BioLegend Recent Developments and Future Plans
Table 95. Bio-Rad Company Information, Head Office, and Major Competitors
Table 96. Bio-Rad Major Business
Table 97. Bio-Rad Anti-CD47 Antibody Product and Solutions
Table 98. Bio-Rad Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Bio-Rad Recent Developments and Future Plans
Table 100. Huabio Company Information, Head Office, and Major Competitors
Table 101. Huabio Major Business
Table 102. Huabio Anti-CD47 Antibody Product and Solutions
Table 103. Huabio Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Huabio Recent Developments and Future Plans
Table 105. BPS Bioscience Company Information, Head Office, and Major Competitors
Table 106. BPS Bioscience Major Business
Table 107. BPS Bioscience Anti-CD47 Antibody Product and Solutions
Table 108. BPS Bioscience Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. BPS Bioscience Recent Developments and Future Plans
Table 110. OriGene Technologies Company Information, Head Office, and Major Competitors
Table 111. OriGene Technologies Major Business
Table 112. OriGene Technologies Anti-CD47 Antibody Product and Solutions
Table 113. OriGene Technologies Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. OriGene Technologies Recent Developments and Future Plans
Table 115. St John's Laboratory Company Information, Head Office, and Major Competitors
Table 116. St John's Laboratory Major Business
Table 117. St John's Laboratory Anti-CD47 Antibody Product and Solutions
Table 118. St John's Laboratory Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. St John's Laboratory Recent Developments and Future Plans
Table 120. Absolute Antibody Company Information, Head Office, and Major Competitors
Table 121. Absolute Antibody Major Business
Table 122. Absolute Antibody Anti-CD47 Antibody Product and Solutions
Table 123. Absolute Antibody Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. Absolute Antibody Recent Developments and Future Plans
Table 125. NSJ Bioreagents Company Information, Head Office, and Major Competitors
Table 126. NSJ Bioreagents Major Business
Table 127. NSJ Bioreagents Anti-CD47 Antibody Product and Solutions
Table 128. NSJ Bioreagents Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 129. NSJ Bioreagents Recent Developments and Future Plans
Table 130. Cell Signaling Technology Company Information, Head Office, and Major Competitors
Table 131. Cell Signaling Technology Major Business
Table 132. Cell Signaling Technology Anti-CD47 Antibody Product and Solutions
Table 133. Cell Signaling Technology Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 134. Cell Signaling Technology Recent Developments and Future Plans
Table 135. RayBiotech Company Information, Head Office, and Major Competitors
Table 136. RayBiotech Major Business
Table 137. RayBiotech Anti-CD47 Antibody Product and Solutions
Table 138. RayBiotech Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 139. RayBiotech Recent Developments and Future Plans
Table 140. Beijing Solarbio Science & Technology Company Information, Head Office, and Major Competitors
Table 141. Beijing Solarbio Science & Technology Major Business
Table 142. Beijing Solarbio Science & Technology Anti-CD47 Antibody Product and Solutions
Table 143. Beijing Solarbio Science & Technology Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 144. Beijing Solarbio Science & Technology Recent Developments and Future Plans
Table 145. Bethyl Laboratories Company Information, Head Office, and Major Competitors
Table 146. Bethyl Laboratories Major Business
Table 147. Bethyl Laboratories Anti-CD47 Antibody Product and Solutions
Table 148. Bethyl Laboratories Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Bethyl Laboratories Recent Developments and Future Plans
Table 150. Abeomics Company Information, Head Office, and Major Competitors
Table 151. Abeomics Major Business
Table 152. Abeomics Anti-CD47 Antibody Product and Solutions
Table 153. Abeomics Anti-CD47 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 154. Abeomics Recent Developments and Future Plans
Table 155. Global Anti-CD47 Antibody Revenue (USD Million) by Players (2019-2024)
Table 156. Global Anti-CD47 Antibody Revenue Share by Players (2019-2024)
Table 157. Breakdown of Anti-CD47 Antibody by Company Type (Tier 1, Tier 2, and Tier 3)
Table 158. Market Position of Players in Anti-CD47 Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 159. Head Office of Key Anti-CD47 Antibody Players
Table 160. Anti-CD47 Antibody Market: Company Product Type Footprint
Table 161. Anti-CD47 Antibody Market: Company Product Application Footprint
Table 162. Anti-CD47 Antibody New Market Entrants and Barriers to Market Entry
Table 163. Anti-CD47 Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 164. Global Anti-CD47 Antibody Consumption Value (USD Million) by Type (2019-2024)
Table 165. Global Anti-CD47 Antibody Consumption Value Share by Type (2019-2024)
Table 166. Global Anti-CD47 Antibody Consumption Value Forecast by Type (2025-2030)
Table 167. Global Anti-CD47 Antibody Consumption Value by Application (2019-2024)
Table 168. Global Anti-CD47 Antibody Consumption Value Forecast by Application (2025-2030)
Table 169. North America Anti-CD47 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 170. North America Anti-CD47 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 171. North America Anti-CD47 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 172. North America Anti-CD47 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 173. North America Anti-CD47 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 174. North America Anti-CD47 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 175. Europe Anti-CD47 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 176. Europe Anti-CD47 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 177. Europe Anti-CD47 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 178. Europe Anti-CD47 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 179. Europe Anti-CD47 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 180. Europe Anti-CD47 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 181. Asia-Pacific Anti-CD47 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 182. Asia-Pacific Anti-CD47 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 183. Asia-Pacific Anti-CD47 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 184. Asia-Pacific Anti-CD47 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 185. Asia-Pacific Anti-CD47 Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 186. Asia-Pacific Anti-CD47 Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 187. South America Anti-CD47 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 188. South America Anti-CD47 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 189. South America Anti-CD47 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 190. South America Anti-CD47 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 191. South America Anti-CD47 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 192. South America Anti-CD47 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 193. Middle East & Africa Anti-CD47 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 194. Middle East & Africa Anti-CD47 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 195. Middle East & Africa Anti-CD47 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 196. Middle East & Africa Anti-CD47 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 197. Middle East & Africa Anti-CD47 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 198. Middle East & Africa Anti-CD47 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 199. Anti-CD47 Antibody Raw Material
Table 200. Key Suppliers of Anti-CD47 Antibody Raw Materials
LIST OF FIGURE
. s
Figure 1. Anti-CD47 Antibody Picture
Figure 2. Global Anti-CD47 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Anti-CD47 Antibody Consumption Value Market Share by Type in 2023
Figure 4. Monoclonal Antibody
Figure 5. Polyclonal Antibody
Figure 6. Global Anti-CD47 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Anti-CD47 Antibody Consumption Value Market Share by Application in 2023
Figure 8. Biotechnology Picture
Figure 9. Medical Picture
Figure 10. University Picture
Figure 11. Others Picture
Figure 12. Global Anti-CD47 Antibody Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Anti-CD47 Antibody Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Anti-CD47 Antibody Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Anti-CD47 Antibody Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Anti-CD47 Antibody Consumption Value Market Share by Region in 2023
Figure 17. North America Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Anti-CD47 Antibody Revenue Share by Players in 2023
Figure 23. Anti-CD47 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Anti-CD47 Antibody Market Share in 2023
Figure 25. Global Top 6 Players Anti-CD47 Antibody Market Share in 2023
Figure 26. Global Anti-CD47 Antibody Consumption Value Share by Type (2019-2024)
Figure 27. Global Anti-CD47 Antibody Market Share Forecast by Type (2025-2030)
Figure 28. Global Anti-CD47 Antibody Consumption Value Share by Application (2019-2024)
Figure 29. Global Anti-CD47 Antibody Market Share Forecast by Application (2025-2030)
Figure 30. North America Anti-CD47 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Anti-CD47 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Anti-CD47 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Anti-CD47 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 40. France Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Anti-CD47 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Anti-CD47 Antibody Consumption Value Market Share by Region (2019-2030)
Figure 47. China Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 50. India Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Anti-CD47 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Anti-CD47 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Anti-CD47 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Anti-CD47 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Anti-CD47 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Anti-CD47 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 64. Anti-CD47 Antibody Market Drivers
Figure 65. Anti-CD47 Antibody Market Restraints
Figure 66. Anti-CD47 Antibody Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Anti-CD47 Antibody in 2023
Figure 69. Manufacturing Process Analysis of Anti-CD47 Antibody
Figure 70. Anti-CD47 Antibody Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
